WuXi XDC Cayman (FRA:L74) Net Cash per Share : €-0.05 (As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is WuXi XDC Cayman Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). WuXi XDC Cayman's Net Cash per Share for the quarter that ended in Jun. 2023 was €-0.05.

The historical rank and industry rank for WuXi XDC Cayman's Net Cash per Share or its related term are showing as below:

FRA:L74' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 7.17 Med: 12.65 Max: 12.65
Current: 7.38

During the past 4 years, the highest Price-to-Net-Cash Ratio of WuXi XDC Cayman was 12.65. The lowest was 7.17. And the median was 12.65.

FRA:L74's Price-to-Net-Cash is ranked worse than
53.85% of 78 companies
in the Medical Diagnostics & Research industry
Industry Median: 7.345 vs FRA:L74: 7.38

WuXi XDC Cayman Net Cash per Share Historical Data

The historical data trend for WuXi XDC Cayman's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi XDC Cayman Net Cash per Share Chart

WuXi XDC Cayman Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Net Cash per Share

-0.10

-0.03

0.30

WuXi XDC Cayman Quarterly Data
	Dec20	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23	Dec23
Net Cash per Share	Get a 7-Day Free Trial			-	-0.03	-0.05	-0.05	0.30

Competitive Comparison of WuXi XDC Cayman's Net Cash per Share

For the Diagnostics & Research subindustry, WuXi XDC Cayman's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

WuXi XDC Cayman's Price-to-Net-Cash Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, WuXi XDC Cayman's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where WuXi XDC Cayman's Price-to-Net-Cash falls into.

WuXi XDC Cayman Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

WuXi XDC Cayman's Net Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as

	Net Cash per Share (A: Dec. 2023 )
=	(Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(519.822	-	164.517	-	0)	/	1197.6
=	0.30

WuXi XDC Cayman's Net Cash per Share for the quarter that ended in Jun. 2023 is calculated as

	Net Cash per Share (Q: Jun. 2023 )
=	(Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(72.388	-	134.212	-	0)	/	1178.45
=	-0.05

WuXi XDC Cayman (FRA:L74) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.

WuXi XDC Cayman Net Cash per Share Related Terms

Thank you for viewing the detailed overview of WuXi XDC Cayman's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

WuXi XDC Cayman (FRA:L74) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » WuXi XDC Cayman Inc (FRA:L74) » Definitions » Net Cash per Share

Comparable Companies

Traded in Other Exchanges

02268:Hong Kong

Address

No. 11 Xinhui Ring Road, Xinwu, Jiangsu, Wuxi, CHN

Website

WuXi XDC Cayman Inc is a leading CRDMO focused on the global ADC and broader bioconjugate market and the only one dedicated to providing integrated and end-to-end services. Leveraging expertise in both biologics and small molecules, It offers interdisciplinary and comprehensive services, covering bioconjugate discovery, research, development and manufacturing. The company provides these services from proximately located, state-of-the-art laboratories and manufacturing facilities, leading to the significant reduction of development timeline and costs. As a fully integrated one-stop bioconjugate discovery, development and manufacturing platform, its mission is to continuously enhance its platform, and propel and transform the development of the bioconjugate industry.

WuXi XDC Cayman (FRA:L74) Headlines

No Headlines